Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Gallo

Showing results (91-100 of 135) with videos related to

Pageof 14
Sort By:
Oncotarget|December 8, 2017
The relevance of prelamin A and RAD51 as molecular biomarkers in cervical cancerSimona Leonardi, Marianna Buttarelli, Ilaria De Stefano, et al.
Histopathology|November 19, 2011
Cytoplasmic expression of oestrogen receptor beta (ERβ) as a prognostic factor in vulvar squamous cell carcinoma in elderly womenGian F Zannoni, Maria G Prisco, Valerio G Vellone, et al.
Plos One|July 8, 2014
Gender effect in experimental models of human medulloblastoma: does the estrogen receptor β signaling play a role?Alessandra Ciucci, Daniela Meco, Ilaria De Stefano, et al.
Human Pathology|August 13, 2011
Prognostic role of metastasis tumor antigen 1 in patients with ovarian cancer: a clinical studyMaria Grazia Prisco, Gian Franco Zannoni, Ilaria De Stefano, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 5, 2022
Identification of a novel gene signature predicting response to first-line chemotherapy in BRCA wild-type high-grade serous ovarian cancer patientsMarianna Buttarelli, Alessandra Ciucci, Fernando Palluzzi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2005
Class III beta-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patientsSimona Mozzetti, Cristiano Ferlini, Paola Concolino, et al.
International Journal of Molecular Sciences|February 13, 2025
Natural Killer Cells in Graves' Disease: Increased Frequency but Impaired Degranulation Ability Compared to Healthy ControlsDaniela Gallo, Eliana Piantanida, Raffaella Bombelli, et al.
Cancers|April 17, 2020
Clinical Value of lncRNA MEG3 in High-Grade Serous Ovarian CancerMarianna Buttarelli, Marta De Donato, Giuseppina Raspaglio, et al.
Cancer Research|August 13, 2009
Paclitaxel directly binds to Bcl-2 and functionally mimics activity of Nur77Cristiano Ferlini, Lucia Cicchillitti, Giuseppina Raspaglio, et al.
Human Pathology|December 26, 2012
The expression ratios of estrogen receptor α (ERα) to estrogen receptor β1 (ERβ1) and ERα to ERβ2 identify poor clinical outcome in endometrioid endometrial cancerGian Franco Zannoni, Giorgia Monterossi, Ilaria De Stefano, et al.
Pageof 14

Showing results (91-100 of 135) with videos related to

Sort By:
Pageof 14
Oncotarget|December 8, 2017
The relevance of prelamin A and RAD51 as molecular biomarkers in cervical cancerSimona Leonardi, Marianna Buttarelli, Ilaria De Stefano, et al.
Histopathology|November 19, 2011
Cytoplasmic expression of oestrogen receptor beta (ERβ) as a prognostic factor in vulvar squamous cell carcinoma in elderly womenGian F Zannoni, Maria G Prisco, Valerio G Vellone, et al.
Plos One|July 8, 2014
Gender effect in experimental models of human medulloblastoma: does the estrogen receptor β signaling play a role?Alessandra Ciucci, Daniela Meco, Ilaria De Stefano, et al.
Human Pathology|August 13, 2011
Prognostic role of metastasis tumor antigen 1 in patients with ovarian cancer: a clinical studyMaria Grazia Prisco, Gian Franco Zannoni, Ilaria De Stefano, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 5, 2022
Identification of a novel gene signature predicting response to first-line chemotherapy in BRCA wild-type high-grade serous ovarian cancer patientsMarianna Buttarelli, Alessandra Ciucci, Fernando Palluzzi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2005
Class III beta-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patientsSimona Mozzetti, Cristiano Ferlini, Paola Concolino, et al.
International Journal of Molecular Sciences|February 13, 2025
Natural Killer Cells in Graves' Disease: Increased Frequency but Impaired Degranulation Ability Compared to Healthy ControlsDaniela Gallo, Eliana Piantanida, Raffaella Bombelli, et al.
Cancers|April 17, 2020
Clinical Value of lncRNA MEG3 in High-Grade Serous Ovarian CancerMarianna Buttarelli, Marta De Donato, Giuseppina Raspaglio, et al.
Cancer Research|August 13, 2009
Paclitaxel directly binds to Bcl-2 and functionally mimics activity of Nur77Cristiano Ferlini, Lucia Cicchillitti, Giuseppina Raspaglio, et al.
Human Pathology|December 26, 2012
The expression ratios of estrogen receptor α (ERα) to estrogen receptor β1 (ERβ1) and ERα to ERβ2 identify poor clinical outcome in endometrioid endometrial cancerGian Franco Zannoni, Giorgia Monterossi, Ilaria De Stefano, et al.
Pageof 14